Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes

Stanford University

Status: Begins enrollment in 5 months

Conditions: Type 2 Diabetes Mellitus (T2DM); Type 2 Diabetes

Treatments: Other: Self-Selected Diet (Control); Other: NOURISH Diet

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT06836479

78525

Details and patient eligibility

About

The investigators are hoping to determine whether tailoring the diet of someone with type 2 diabetes to their ethnic group while following American Diabetes Association guidelines can make a significant difference in their blood sugar controls. Participants will be required to wear a Continuous Glucose Monitor (CGM) for 1-month so that the investigators can compare blood sugar levels when participants are eating their routine diet vs. the culturally tailored diabetes diet.

Full description

This clinical trial evaluates the impact of culturally tailored, American Diabetes Association (ADA)-compliant meals on the glycemic control of Asian Indian and Filipino individuals with Type 2 Diabetes Mellitus (T2DM). This study leverages a crossover design to compare glycemic responses during two distinct dietary phases: a self-selected diet phase (baseline/control/routine diet) and an intervention phase featuring NOURISH meals. NOURISH Meals will be delivered to designated pick-up points on the Stanford campus and Stanford clinics. Participants will be equipped with Continuous Glucose Monitors (CGMs) to track glucose trends across the study and will be required to keep a food log through Tastermonial, enabling detailed analysis of postprandial glucose responses and key metrics.

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Self-identification as Asian Indian or Filipino
• Diagnosed with T2DM
• Can pick up meals from a designated area on the Stanford Campus
• Willing to wear a CGM for 30 days

Exclusion criteria

• Currently taking insulin, GLP -1 and SGLT 2
• Known severe allergic reactions and/or food intolerances that would interfere with the ability to eat
• Those who, in the opinion of the investigators, cannot reliably complete the study protocol.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

30 participants in 2 patient groups

Self Selected Diet to NOURISH Diet

Experimental group

Description:

Participants in this arm will be consuming self-selected meals (baseline/control) first (During Week 2 of the intervention), followed by the NOURISH diet in the next week (Week 3). Participants will be required to fill out a food diary and questionnaires using the Tastermonital app.

Treatment:

Other: NOURISH Diet

Other: Self-Selected Diet (Control)

NOURISH Diet to Self-Selected Diet

Experimental group

Description:

Participants in this arm will be consuming the NOURISH diet first (During Week 2 of the intervention), followed by their self-selected diet (baseline/control) in the next week (Week 3). Participants will be required to fill out a food diary and questionnaires using the Tastermonital app.

Treatment:

Other: NOURISH Diet

Other: Self-Selected Diet (Control)